Renascience Pharma Limited
Registered name: RENASCIENCE PHARMA LIMITED
Part of Lupin Atlantis Holdings Sa groupRenascience Pharma Limited made £3.7m revenue and £1.3m profit in the year to 31 Mar 2025.
Renascience Pharma Limited’s revenue grew 97% to £3.7m in the year to 31 Mar 2025, with £1.3m profit and 4 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Slough; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Slough, South East
- Age
- 11 yrs · since 2015
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 28 Feb 2022 | 28 Feb 2023 | 29 Feb 2024 | 31 Mar 2025 |
|---|---|---|---|---|
| Disclosure | No P&L | No P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | — | — | £1.9m | £3.7m |
| Profit after tax | — | — | £541k | £1.3m |
| Profit (best available) | — | — | £541k | £1.3m |
| Employees (average) | 2 | 0 | 0 | 4 |
| Ratios | ||||
| Profit margin | — | — | 28.8% | 35.6% |
| Revenue per employee | — | — | — | £921k |
| Profit per employee | — | — | — | £328k |
| Growth (year on year) | ||||
| Revenue growth | — | — | — | ▲96.6% |
| Profit growth | — | — | — | ▲142.6% |
| Headcount growth | — | ▼100% | — | — |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | — | £245k | £348k | £902k |
| Net assets | £77.1k | £308k | £249k | £960k |
| Fixed assets | £18.1k | £9.8k | £6.4k | — |
| Current assets | £117k | £386k | £579k | £1.8m |
| Debtors | — | £13.4k | £107k | £720k |
| Cash from operations | — | — | £705k | £1.2m |
| Source | FilletedAccounts · bulk data Oct 2023 | FilletedAccounts · bulk data Oct 2023 | FilletedAccounts · bulk data Nov 2024 | FullAccounts · bulk data Mar 2026 |
How the business works
- Profit margin
- 35.6%
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £921k
- Revenue ÷ average employees.
- Profit per employee
- £328k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 19.5%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲286%
- Now £960k
- Cash at bank
- ▲159%
- Now £902k
- Headcount
- —
- Now 4
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Lupin Atlantis Holdings Sa (registered outside the UK register)ultimate parent75–100%
- Lupin Healthcare (UK) Limited75–100%
- Renascience Pharma Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- New Nordic LimitedLyndhurst · Manufacture of basic pharmaceutical products
- Revenue
- £7.4m
- Profit
- £125k
- Staff
- 5
- Ascot Laboratories LimitedBorehamwood · Manufacture of basic pharmaceutical products
- Revenue
- £8.9m
- Profit
- £645k
- Staff
- 66
- Vector Consumer LimitedPrenton · Manufacture of basic pharmaceutical products
- Revenue
- £10.6m
- Profit
- £33.1k
- Staff
- 14
- Pharmapac (U.K.) LimitedBidston, Wirral · Manufacture of basic pharmaceutical products
- Revenue
- £10.8m
- Profit
- £94.7k
- Staff
- 142
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit £1.3m), from the Companies House accounts bulk data published Mar 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.